Beginning Cash: The amount of cash reported by the company on its previous statement.
Rhythm Pharmaceuticals, Inc. (RYTM) had Beginning Cash of $54.82M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$71.25M |
|
$-50.36M |
|
$8.93M |
|
$62.32M |
|
$119.81M |
|
$-48.55M |
|
$-0.30M |
|
$-48.85M |
|
$-48.85M |
|
$-49.30M |
|
$-49.30M |
|
$-49.30M |
|
$-49.30M |
|
$-48.55M |
|
$-48.30M |
|
68.59M |
|
68.59M |
|
$-0.73 |
|
$-0.73 |
|
| Balance Sheet Financials | |
$426.56M |
|
$0.10M |
|
$10.70M |
|
$437.27M |
|
$123.59M |
|
-- |
|
$96.38M |
|
$219.97M |
|
$102.98M |
|
$212.41M |
|
$217.30M |
|
68.82M |
|
| Cash Flow Statement Financials | |
$-53.34M |
|
$71.06M |
|
$-6.57M |
|
|
Beginning Cash |
$54.82M |
$66.22M |
|
$11.39M |
|
$49.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
87.47% |
|
-68.14% |
|
-68.14% |
|
-- |
|
-68.56% |
|
-70.68% |
|
$-53.34M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.29 |
|
1.76 |
|
51.04 |
|
-47.87% |
|
-23.21% |
|
-11.27% |
|
-22.69% |
|
$3.16 |
|
$-0.78 |
|
$-0.78 |
|